Synopsys Clears Final Regulatory Hurdle for $35B Ansys Deal

Synopsys (SNPS) has secured conditional approval from Chinese regulators for its $35 billion acquisition of Ansys (ANSS), clearing the final regulatory hurdle for the deal. The approval, which was reportedly delayed amid U.S.-China technology export tensions, requires the combined entity to maintain existing contracts with Chinese customers. Expected to close by Thursday, the news sent Ansys shares up 4%, while Synopsys shares remained largely unchanged.

Analysis

Synopsys (SNPS) has secured the final regulatory green light for its $35 billion acquisition of Ansys (ANSS) after receiving conditional approval from China's State Administration for Market Regulation. This development removes a significant overhang for the deal, which was reportedly delayed by U.S.-China geopolitical tensions over technology trade. The approval is contingent upon the combined entity honoring existing contracts with Chinese customers, a condition that secures near-term revenue but imposes an operational constraint. The transaction is now expected to close by Thursday, with the deal structure providing Ansys shareholders with $197 in cash and 0.3450 shares of Synopsys stock per share. The market's reaction underscores the removal of uncertainty, with Ansys shares climbing 4% to near all-time highs, while Synopsys shares remained stable, having already gained 16% year-to-date, suggesting the positive outcome was largely anticipated by investors in the acquirer.

Key Decisions for Investors

• Ansys shareholders should anticipate the deal closing imminently, effectively locking in the value of $197 in cash plus 0.3450 Synopsys shares and eliminating the merger arbitrage play.
• For Synopsys investors, the focus now shifts from regulatory risk to execution risk; key monitoring points will be the successful integration of Ansys and the long-term strategic implications of the condition to maintain service for Chinese clients.
• The resolution of this deal suggests that critical, strategic M&A can still navigate geopolitical hurdles, though investors should note that attached conditions, like mandated service continuation, may become a more common feature in cross-border tech approvals.